Robert Downham

This inventor holds 20 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Astex Therapeutics Limited, Norgine Bv, Alizyme Therapeutics Limited. Active years: 2003-2018.

USPTO Granted Patents = 20 (Patent Applications = 2)

% Patents Active = 25.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 104(Granted Patents)

Location History:

Newmarket, GB (2010 - 2016)
Manchester, GB (2012 - 2016)
Cambridge, GB (2003 - 2018)

Company Filing History:

8 out of 126

Astex Therapeutics Limited

Alizyme Therapeutics Limited

patents

4. 3 out of 268

Cancer Research Technology Limited

patents

5. 3 out of 54

The Institute of Cancer Research: Royal Cancer Hospital

F2g Limited British Body Corporate

patent

8. 1 out of 1

F2g Ltd British Body Corporate

patent

9. 1 out of 854

Millennium Pharmaceuticals Limited

patents

where one patent can have more than one assignee

Years Active: 2003-2018

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9914719 - Hydroxybenzamide derivatives and their use as inhibitors of HSP90 (2018-03-13),

2. 9452168 - Pyrrole antifungal agents (2016-09-27),

3. 9283226 - Pyrazole derivatives as protein kinase modulators (2016-03-15),

4. 9029411 - Thiophenes and uses thereof (2015-05-12),

5. 8993574 - Pyrrole antifungal agents (2015-03-31),

6. 8877750 - 2-oxy-benzoxazinone derivatives for the treatment of obesity (2014-11-04),

7. 8691806 - Pyrazole derivatives as protein kinase modulators (2014-04-08),

8. 8604029 - 2-[(2-substituted)-indolizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents (2013-12-10),

9. 8530469 - Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 (2013-09-10),

10. 8524705 - 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl)-acetamide derivatives and related compounds as antifungal agents (2013-09-03),

11. 8247576 - Pyrazole derivatives as protein kinase modulators (2012-08-21),

12. 8106057 - Dihydroxyphenyl isoindolylmethanones (2012-01-31),

13. 8101648 - Hydroxybenzamide derivatives and their use as inhibitors of HSP90 (2012-01-24),

14. 7858617 - 2-oxy-benzoxazinone derivatives for the treatment of obesity (2010-12-28),

15. 7825113 - 2-oxy-benzoxazinone derivatives for the treatment of obesity (2010-11-02),

Title: Innovations and Patents of Robert Downham

Introduction

Robert Downham, an accomplished inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceuticals with a total of 20 patents to his name. His innovative work primarily focuses on the development of compounds that serve as inhibitors for various biological processes, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Among his latest inventions are hydroxybenzamide derivatives, which are recognized for their activity as HSP90 inhibitors. This invention provides a range of compounds characterized by complex chemical structures, indicating their potential for significant therapeutic applications. Additionally, he has developed pyrrole antifungal agents, which are designed for the prevention and treatment of fungal diseases, proving to be useful both in medicinal and agricultural fields. These compounds demonstrate promising utility in combating certain diseases, thus contributing to healthcare and agricultural practices.

Career Highlights

Robert Downham has worked with notable companies, including Astex Therapeutics Limited and Norgine BV, where he furthered his research and development efforts. His career reflects a strong commitment to innovation in pharmacology, particularly in developing treatments that address unmet medical needs.

Collaborations

Throughout his career, Robert has collaborated with esteemed colleagues such as Harold Francis Hodson and Christopher Robert Dunk. These collaborations highlight a spirit of teamwork in the pursuit of scientific discovery and problem-solving in the realm of drug development.

Conclusion

In conclusion, Robert Downham's contributions through his inventions and patents demonstrate his impact on the pharmaceutical industry. His work not only showcases his ingenuity but also plays a critical role in advancing medical therapies, ultimately benefiting society at large. With continued innovation, Robert is poised to make even more significant strides in the field of medicinal chemistry.